FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity.

Perhaps Ally McBeal can ease her off-the-charts stress levels by escaping to the office restroom. But for most of us, public toilets are actually a bit scary. If you squirm at the thought of ...

Mental health issues, such as depression and substance use, often peak during the holidays, but research has shown that just ...

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

COVID-19 continues to retreat from being a top cause of death in the U.S., and in turn, life expectancy last year rebounded further toward pre-pandemic longevity.

There’s no one-size-fits all number that applies to everyone. “But we know that even 7% to 10% of weight loss can have a ...

New CDC data shows that in a survey, 24% of adults said they had pain most days or every day during the past three months.

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.